Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phillip Scott

Showing results (31-40 of 130) with videos related to

Pageof 13
Sort By:
Immunological Reviews|September 14, 2004
The development of effector and memory T cells in cutaneous leishmaniasis: the implications for vaccine developmentPhillip Scott, David Artis, Jude Uzonna, et al.
Frontiers in Immunology|April 12, 2021
Host-Directed Therapies for Cutaneous LeishmaniasisFernanda O Novais, Camila Farias Amorim, Phillip Scott
Journal of Immunology (Baltimore, Md. : 1950)|May 23, 2002
The role of IL-12 in maintaining resistance to Leishmania majorAudrey Y Park, Brian Hondowicz, Manfred Kopf, et al.
Parasite Immunology|August 8, 2002
Schistosomiasis delays lesion resolution during Leishmania major infection by impairing parasite killing by macrophagesAnne Camille La Flamme, Phillip Scott, Edward J Pearce
Nature Medicine|September 28, 2004
Central memory T cells mediate long-term immunity to Leishmania major in the absence of persistent parasitesColby Zaph, Jude Uzonna, Stephen M Beverley, et al.
The Journal of Cell Biology|September 29, 2023
PLK4 self-phosphorylation drives the selection of a single site for procentriole assemblyPhillip Scott, Ana Curinha, Colin Gliech, et al.
Immunological Reviews|November 18, 2004
The role of IL-27 in the development of T-cell responses during parasitic infectionsChristopher A Hunter, Alejandro Villarino, David Artis, et al.
Infection and Immunity|September 14, 2002
Combined treatment with interleukin-12 and indomethacin promotes increased resistance in BALB/c mice with established Leishmania major infectionsJian Li, Udaikumar M Padigel, Phillip Scott, et al.
The Journal of Experimental Medicine|March 3, 2004
MHC class II expression restricted to CD8alpha+ and CD11b+ dendritic cells is sufficient for control of Leishmania majorMaria P Lemos, Fatima Esquivel, Phillip Scott, et al.
Infection and Immunity|December 22, 2005
Immunization with persistent attenuated Delta lpg2 Leishmania major parasites requires adjuvant to provide protective immunity in C57BL/6 miceChahnaz Kébaïer, Jude E Uzonna, Stephen M Beverley, et al.
Pageof 13

Showing results (31-40 of 130) with videos related to

Sort By:
Pageof 13
Immunological Reviews|September 14, 2004
The development of effector and memory T cells in cutaneous leishmaniasis: the implications for vaccine developmentPhillip Scott, David Artis, Jude Uzonna, et al.
Frontiers in Immunology|April 12, 2021
Host-Directed Therapies for Cutaneous LeishmaniasisFernanda O Novais, Camila Farias Amorim, Phillip Scott
Journal of Immunology (Baltimore, Md. : 1950)|May 23, 2002
The role of IL-12 in maintaining resistance to Leishmania majorAudrey Y Park, Brian Hondowicz, Manfred Kopf, et al.
Parasite Immunology|August 8, 2002
Schistosomiasis delays lesion resolution during Leishmania major infection by impairing parasite killing by macrophagesAnne Camille La Flamme, Phillip Scott, Edward J Pearce
Nature Medicine|September 28, 2004
Central memory T cells mediate long-term immunity to Leishmania major in the absence of persistent parasitesColby Zaph, Jude Uzonna, Stephen M Beverley, et al.
The Journal of Cell Biology|September 29, 2023
PLK4 self-phosphorylation drives the selection of a single site for procentriole assemblyPhillip Scott, Ana Curinha, Colin Gliech, et al.
Immunological Reviews|November 18, 2004
The role of IL-27 in the development of T-cell responses during parasitic infectionsChristopher A Hunter, Alejandro Villarino, David Artis, et al.
Infection and Immunity|September 14, 2002
Combined treatment with interleukin-12 and indomethacin promotes increased resistance in BALB/c mice with established Leishmania major infectionsJian Li, Udaikumar M Padigel, Phillip Scott, et al.
The Journal of Experimental Medicine|March 3, 2004
MHC class II expression restricted to CD8alpha+ and CD11b+ dendritic cells is sufficient for control of Leishmania majorMaria P Lemos, Fatima Esquivel, Phillip Scott, et al.
Infection and Immunity|December 22, 2005
Immunization with persistent attenuated Delta lpg2 Leishmania major parasites requires adjuvant to provide protective immunity in C57BL/6 miceChahnaz Kébaïer, Jude E Uzonna, Stephen M Beverley, et al.
Pageof 13